UPC Analytics
ENDE
Overview · Filed:

ACT_16116/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

InfringementMain Infringement ActionMunich LDInfringement Action
  • 2025-09-15Procedural onlyproceduralInfringement Action

    Procedural scheduling order by Munich Local Division (UPC_CFI_145-148/2024, 15 September 2025) summoning party experts to oral hearing on 14-17 October 2025 in four consolidated infringement proceedings by Sanofi entities against Accord Healthcare, STADA, Reddy Pharma/betapharm and Zentiva groups concerning EP 2 493 466.